For UK Healthcare Professionals only

Request a visit

Request an Uzpruvo▼ (ustekinumab) visit

Uzpruvo is indicated for the treatment of moderate to severe Crohn’s disease in adults, moderate to severe plaque psoriasis in adults, moderate to severe paediatric plaque psoriasis and psoriatic arthritis in adults.

Prescribing Information can be found here.

Please leave your details below if you would like more information about Uzpruvo. Should you have any trouble completing this form please email us at HCPsupport@thorntonross.com

Required fields are marked with an asterisk *

    What would you like to discuss?

    Discuss with the Healthcare Partnership Manager

    Discuss with the Medical Science Liaison

    Your details

    Name

    NHS Email* / Phone number

    Professional Code

    Role*

    Hospital/Practice Details*

    NHS Work Address*

    Please tick to confirm

    Let’s stay connected!

    Want to be the first to hear about the products, services and educational resources we offer, including invitations to webinars and events.

    You can unsubscribe at any time by clicking the link in the footer of our emails. For information about how we process your data, please visit our website.

    Should you have any trouble completing this form please email us at HCPsupport@thorntonross.com

    Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Thornton and Ross Limited by emailing thorntonross@medinformation.co.uk or by calling 01484 848164.

    UK-UZPRU-24(1) | August 2024